Pain Hustlers is a 2023 American crime drama film directed by David Yates and written by Wells Tower. It is based on the 2022 book of the same name by Evan Hughes and stars Emily Blunt, Chris Evans, and Andy García. The film tells the true story of Liza Drake, a high school dropout who lands a job with a failing pharmaceutical company in Central Florida and soon finds herself at the center of a criminal conspiracy involving the illegal marketing and sale of opioids.
Table of Contents
The Rise of Insys Therapeutics
The pharmaceutical company at the center of the Pain Hustlers scandal is Insys Therapeutics. Insys was founded in 2002 by billionaire John Kapoor, who was obsessed with developing a new generation of opioid painkillers. In 2012, Insys launched its flagship product, Subsys, a fentanyl-based spray that was marketed as a treatment for breakthrough cancer pain.
Subsys was immediately successful, generating billions of dollars in revenue for Insys. However, the company’s success was built on a foundation of fraud and deception. Insys executives knew that Subsys was highly addictive and had a number of serious side effects, but they aggressively marketed the drug to doctors and patients alike, downplaying the risks and exaggerating the benefits.
The Speaker Program
One of the key ways that Insys marketed Subsys was through its “speaker program.” Under the guise of providing continuing education to doctors, Insys paid physicians to give talks about Subsys to their colleagues. In reality, the speaker program was a front for bribery. Insys executives paid doctors lavish fees to give talks about Subsys, even if they had no experience with the drug or had never even prescribed it to a patient.
The speaker program was extremely effective in boosting sales of Subsys. In 2015, Insys spent over $300 million on the program, and sales of Subsys increased by over 500%. However, the speaker program also led to a number of doctors overprescribing Subsys to their patients, resulting in a wave of addiction and overdose deaths.
The Fall of Insys Therapeutics
In 2016, the FBI launched an investigation into Insys Therapeutics. The investigation uncovered a massive criminal conspiracy involving illegal kickbacks, bribery, and money laundering. In 2018, John Kapoor and several other Insys executives were convicted of racketeering conspiracy and sentenced to prison.
The Insys scandal was a major setback for the pharmaceutical industry and exposed the dark side of the opioid crisis. The story of Pain Hustlers is a cautionary tale about the dangers of greed and corruption, and the importance of holding corporations accountable for their actions.
Impact of the Pain Hustlers Scandal
The Pain Hustlers scandal had a significant impact on the pharmaceutical industry and the opioid crisis. The scandal exposed the aggressive marketing tactics and unethical behavior that some pharmaceutical companies use to sell their products. It also led to increased scrutiny of the speaker program and other marketing practices.
The scandal also had a significant impact on patients. The overprescription of Subsys and other opioids led to a wave of addiction and overdose deaths. The scandal also eroded public trust in the pharmaceutical industry and made it more difficult for patients to access the medications they need.
Lessons Learned from the Pain Hustlers Scandal
The Pain Hustlers scandal is a reminder of the importance of corporate accountability and the need to protect patients from unethical marketing practices. The scandal also highlights the need for reform in the pharmaceutical industry, including stricter oversight of marketing practices and increased transparency about the risks and benefits of prescription drugs.
Here are some specific lessons that can be learned from the Pain Hustlers scandal:
- Pharmaceutical companies should be held accountable for their marketing practices.
- The speaker program is a conflict of interest and should be banned.
- Patients need to be better informed about the risks and benefits of prescription drugs.
- The pharmaceutical industry needs to be more transparent about its marketing practices.
- The government needs to do more to regulate the pharmaceutical industry and protect patients.
The Pain Hustlers scandal is a cautionary tale about the dangers of greed and corruption. It is also a reminder of the importance of corporate accountability and the need to protect patients from unethical marketing practices. The scandal highlights the need for reform in the pharmaceutical industry, and it is important to learn the lessons of the scandal to prevent similar tragedies from happening in the future.